FR2322592A1 - Nouveaux sulfonamides, leur preparation et leur application comme medicaments - Google Patents
Nouveaux sulfonamides, leur preparation et leur application comme medicamentsInfo
- Publication number
- FR2322592A1 FR2322592A1 FR7626461A FR7626461A FR2322592A1 FR 2322592 A1 FR2322592 A1 FR 2322592A1 FR 7626461 A FR7626461 A FR 7626461A FR 7626461 A FR7626461 A FR 7626461A FR 2322592 A1 FR2322592 A1 FR 2322592A1
- Authority
- FR
- France
- Prior art keywords
- alkyl
- prepd
- opt
- chloro
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003456 sulfonamides Chemical class 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 208000006673 asthma Diseases 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229950001656 dioxamate Drugs 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- -1 pyrrolidino, piperidino Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1136775 | 1975-09-02 | ||
| CH1136675 | 1975-09-02 | ||
| CH1419475 | 1975-11-04 | ||
| CH21876 | 1976-01-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2322592A1 true FR2322592A1 (fr) | 1977-04-01 |
| FR2322592B1 FR2322592B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1978-11-17 |
Family
ID=27427797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7626461A Granted FR2322592A1 (fr) | 1975-09-02 | 1976-09-02 | Nouveaux sulfonamides, leur preparation et leur application comme medicaments |
Country Status (11)
-
1976
- 1976-08-23 DE DE19762637882 patent/DE2637882A1/de active Pending
- 1976-08-24 DK DK380176A patent/DK380176A/da unknown
- 1976-08-24 FI FI762419A patent/FI762419A7/fi not_active Application Discontinuation
- 1976-08-25 NO NO762922A patent/NO762922L/no unknown
- 1976-08-26 SE SE7609494A patent/SE7609494L/xx unknown
- 1976-08-31 PT PT65538A patent/PT65538B/pt unknown
- 1976-08-31 IL IL50390A patent/IL50390A0/xx unknown
- 1976-08-31 ES ES451113A patent/ES451113A1/es not_active Expired
- 1976-09-01 AU AU17373/76A patent/AU1737376A/en not_active Expired
- 1976-09-01 JP JP51103766A patent/JPS5233645A/ja active Pending
- 1976-09-02 FR FR7626461A patent/FR2322592A1/fr active Granted
Non-Patent Citations (1)
| Title |
|---|
| NEANT * |
Also Published As
| Publication number | Publication date |
|---|---|
| ES451113A1 (es) | 1977-11-16 |
| DE2637882A1 (de) | 1977-03-03 |
| SE7609494L (sv) | 1977-03-03 |
| AU1737376A (en) | 1978-03-09 |
| JPS5233645A (en) | 1977-03-14 |
| DK380176A (da) | 1977-03-03 |
| PT65538A (fr) | 1976-09-01 |
| FI762419A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-03-03 |
| PT65538B (fr) | 1978-05-10 |
| IL50390A0 (en) | 1976-10-31 |
| FR2322592B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1978-11-17 |
| NO762922L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8305356A1 (es) | Un procedimiento para la produccion de un derivado de carbostirilo | |
| YU61595A (sh) | Nova naftilna jedinjenja, njihovi intermedijeri farmaceutske kompozicije, i postupci za dobijanje tih jedinjenja | |
| HUP9801995A2 (hu) | Helyettesített pirimidin-tioalkil- és -alkil-éter-vegyületek és alkalmazásuk gyógyszerkészítmények előállítására | |
| IE792074L (en) | Pyran- and thiopyran-fused heterocyclic compounds | |
| ES8105299A1 (es) | Procedimiento para preparar aroilimidazol-2-onas | |
| GB1448437A (en) | Diphenylpropylamines | |
| FI56389B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 18-metyl-4,15-estradienderivat | |
| ES448646A1 (es) | Procedimiento para preparar bencenosulfonamidas sustituidas en n. | |
| ES482472A1 (es) | Procedimiento para la preparacion de isoquinoleinas. | |
| MY113427A (en) | Anti-neurodegeneratively active 10-aminoaliphatyl- dibenz [b,f] oxepines | |
| IL66835A0 (en) | Triazoloquinazolone derivatives and their salts,their preparation,their use as medicaments and the compositions containing them | |
| ES467069A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol | |
| FR2322592A1 (fr) | Nouveaux sulfonamides, leur preparation et leur application comme medicaments | |
| GB1185934A (en) | Derivatives of 1,3(2H,4H)-Dioxoisoquinoline and preparation thereof | |
| SE7506058L (sv) | Forfarande for framstellning av 1h-tetrazolderivat med terapeutisk verkan | |
| AU568122B2 (en) | Pharmaceutical bis(piperazinyl or homopiperazinyl) compounds | |
| NL7609616A (en) | (5)-Amino sulphonyl-benzene-(1,3)-dioxamic acids and esters - inhibitors of histamine release, useful e.g. in asthma treatment | |
| ES8203901A1 (es) | Un procedimiento para la preparacion de benzamidas. | |
| YU6996A (sh) | Upotreba benzotiofena za dobijanje leka | |
| ES8305336A1 (es) | "un metodo de preparar una 4-ariloxi-1,2,3,4-tetrahidroisoquinoleina". | |
| NZ216125A (en) | Isoxazoles and pharmaceutical compositions | |
| SE7403176L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| ES8105714A1 (es) | Un procedimiento para preparar compuestos de 5-(7-cloro-4- quinolinil)amino)-3-(aminometil)-(1,1'-bifenil)-2-ol susti- tuidos | |
| ES8101074A1 (es) | Procedimiento para la preparacion de derivados de xantina | |
| ES8107206A1 (es) | Procedimiento para obtener derivados de tiazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |